Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.59
- Piotroski Score 3.00
- Grade Buy
- Symbol (HOWL)
- Company Werewolf Therapeutics, Inc.
- Price $2.02
- Changes Percentage (0%)
- Change -$0
- Day Low $1.97
- Day High $2.10
- Year High $8.19
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $12.00
- High Stock Price Target $12.00
- Low Stock Price Target $12.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.10
- Trailing P/E Ratio -3.17
- Forward P/E Ratio -3.17
- P/E Growth -3.17
- Net Income $-37,368,000
Income Statement
Quarterly
Annual
Latest News of HOWL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Howl of fame 🐺
George Clooney and Brad Pitt star in the action comedy "Wolfs" on Apple TV+....
By USA Today | 6 days ago -
200% Wolf review - moon spirit baby turns kiddie werewolf sequel into frenetic howler
The sequel to 100% Wolf lacks the charm and entertainment of the original, with a chaotic and frenetic storyline that may give viewers a headache....
By The Guardian | 2 weeks ago -
Consumers howl after PG&E announces new rate hike
PG&E plans to request a rate increase to cover costs incurred during the winter of 2022. Kara St. Cyr provides details on this development. Follow updates on their website, YouTube, Facebook, Instagra...
By CBS News | 4 weeks ago
